Tranexamic acid to reduce bleeding after dental extraction in patients treated with non-vitamin K oral anticoagulants: design and rationale of the EXTRACT-NOAC trial.

[1]  R. Jacobs,et al.  Local haemostatic measures after tooth removal in patients on antithrombotic therapy: a systematic review , 2018, Clinical Oral Investigations.

[2]  A. Camm,et al.  The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. , 2018, European heart journal.

[3]  P. Verhamme,et al.  Pragmatic approach to manage new oral anticoagulants in patients undergoing dental extractions: a prospective case-control study , 2017, Clinical Oral Investigations.

[4]  S. Johnston.  An evidence summary of the management of patients taking direct oral anticoagulants (DOACs) undergoing dental surgery. , 2016, International journal of oral and maxillofacial surgery.

[5]  M. Heiland,et al.  Postoperative bleeding risk for oral surgery under continued rivaroxaban anticoagulant therapy , 2016, Clinical Oral Investigations.

[6]  A. Camm,et al.  Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[7]  V. Hasselblad,et al.  Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. , 2015, The New England journal of medicine.

[8]  M. Blombäck,et al.  Tranexamic acid--an old drug still going strong and making a revival. , 2015, Thrombosis research.

[9]  G. Yamane,et al.  Evaluation of postextraction bleeding incidence to compare patients receiving and not receiving warfarin therapy: a cross-sectional, multicentre, observational study , 2014, BMJ Open.

[10]  J. Hirsh,et al.  Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials , 2014, Thrombosis and Haemostasis.

[11]  Alexander Parkhomenko,et al.  Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials , 2014, The Lancet.

[12]  E. Antman,et al.  Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.

[13]  I. Roberts,et al.  Topical application of tranexamic acid for the reduction of bleeding. , 2013, The Cochrane database of systematic reviews.

[14]  D. Atar,et al.  Apixaban versus warfarin in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[15]  G. Breithardt,et al.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.

[16]  S. Yusuf,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[17]  J. Douketis,et al.  Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis. , 2009, Texas dental journal.

[18]  M. Blombäck,et al.  Prevention of postsurgical bleeding in oral surgery using tranexamic acid without dose modification of oral anticoagulants. , 1993, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[19]  S. Sindet‐Pedersen,et al.  Distribution of Tranexamic Acid to Plasma and Saliva After Oral Administration and Mouth Rinsing: A Pharmacokinetic Study , 1987, Journal of clinical pharmacology.